DAVID GURWITZ
Gene drive is the practice of stimulating biased inheritance of particular genes to alter entire populations. Possible alterations include adding, disrupting, or modifying genes, —– Wikipedia
.Dr. David Gurwitz directs the National Laboratory for the Genetics of Israeli Populations (NLGIP) at the Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel-Aviv University, since 1995. He earned a PhD in Biochemistry from Tel-Aviv University and conducted post- graduate studies at the University of California, Irvine. His current research is focused on pharmacogenomics and treatment biomarkers for CNS drugs. He is affiliate member of the NIH Pharmacogenetics Research Network (PGRN) and of international biobanking organizations, and advised the European Commission on pharmacogenomics. He published over 150 manuscripts, including in Nature and Science, and serves as a senior editor of Pharmacogenomics and as editorial board member for several reputable journals, including Trends in Molecular Medicine, Genome Medicine, and Drug Development Research.
